关键数据
19.060今开
19.570最高
42.54K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.25%换手率
19.240昨收
18.408最低
557.41K成交额
亏损市盈率静
2.62市净率
0.00%股息率 TTM
-17.27%ROA
23.63052周最高
0.49量比
-46.30M净利润
17.00M总股本
-2.6835每股收益TTM
0.21Beta
-20.79%ROE
5.58052周最低
6.04%振幅
64.76%毛利率
319.55M总市值
1.87回报/风险
5.34%风险率
操作建议
Prenetics Global Ltd当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名75/385位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价33.00。中期看,股价处于上升通道。近一个月,市场表现较强,基本面评分较高,但较强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Prenetics Global Ltd亮点
亮点风险
Prenetics Global Ltd新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Prenetics Global Ltd简介
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
公司代码PRE
公司Prenetics Global Ltd
CEOKwok (Samantha)
网址https://ir.prenetics.com/
公司股东
常见问题
Prenetics Global Ltd(PRE)的当前股价是多少?
Prenetics Global Ltd(PRE)的当前股价是 18.64。
Prenetics Global Ltd的股票代码是什么?
Prenetics Global Ltd的股票代码是PRE。
Prenetics Global Ltd股票的52周最高点是多少?
Prenetics Global Ltd股票的52周最高点是23.63。
Prenetics Global Ltd股票的52周最低点是多少?
Prenetics Global Ltd股票的52周最低点是5.58。
Prenetics Global Ltd的市值是多少?
Prenetics Global Ltd的市值是319.55M。
现在Prenetics Global Ltd(PRE)的股票是买入、持有还是卖出?
根据分析师评级,Prenetics Global Ltd(PRE)的总体评级为买入,目标价格为33.00。
Prenetics Global Ltd(PRE)股票的每股收益(EPS TTM)是多少
Prenetics Global Ltd(PRE)股票的每股收益(EPS TTM)是-2.68。